β¨ Health Notices
NEW ZEALAND GAZETTE
No. 57
Health
Medicines Act 1981
Corrigendum
Consent to the Distribution of Changed Medicines
In the notice published in the New Zealand Gazette, 16 May 1996, No. 48, page 1301, notice number 3161, delete the word "sodium" in the 13th line. The name of the active ingredient will then read "ganciclovir".
Dated this 31st day of May 1996.
HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
g0361/4
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamivudine 150 mg | Tablet | Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom | 3TC |
| Lamivudine 10 mg/mL in 240 mL | Oral solution | Glaxo Operations UK Limited, Speke, Liverpool, United Kingdom | 3TC |
| Saquinavir mesylate 228.7 mg equivalent to 200 mg saquinavir free base | Capsule | F Hoffmann-La Roche Limited, Basle, Switzerland | Invirase |
Note: These provisional consents are valid for 2 years from the date of publication of this notice.
Dated this 30th day of May 1996.
HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
g0361/2
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Acetylsalicylic acid 150 mg | Tablet | Stevens Chem Industries (NZ) Limited, Pakuranga, Auckland | Aspec |
| Benzoyl peroxide 10% w/w in 10 g, 50 g | Gel, topical | Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France | Benzac AC 10 gel |
| Benzoyl peroxide 2.5% w/w in 10 g, 50 g | Gel, topical | Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France | Benzac AC 2.5 gel |
| Benzoyl peroxide 5% w/w in 10 g, 50 g | Gel, topical | Galderma Laboratories, de Mont Desir, Alby Sur Cheran, France | Benzac AC 5 gel |
| Rocuronium bromide 10 mg/mL in 5 mL, 10 mL, 25 mL | Solution for injection (vials) | Organon International BV., Oss, The Netherlands | Esmeron |
| Somatropin 18IU, 36IU, 72IU equivalent to 6.66 mg, 13.32 mg 26.64 mg respectively plus 3.15 mL of diluent | Injection, cartridge and syringe (diluent only) | Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA., Fegersheim, France. Diluent only: Federa Society Co-operative, Brussels, Belgium | Humatrope |
| Somatropin 4IU, 16IU | Injection, powder (vial) | Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France SA., Fegersheim, France | Humatrope |
| Risperidone 1 mg, 2 mg, 3 mg 4 mg | Tablets | Janssen Cilag SpA., Borgo S. Michele, Latina, Italy and Janssen Pharmaceutica nv., Beerse, Belgium | Risperdal |
| Roxithromycin 50 mg | Tablet, dispersible | Roussel-Uclaf, Usiphar Production Unit, Compiegne, France | Rulide D |
| Lansoprazole 15 mg, 30 mg | Capsules | Lederle Laboratories, Cyanamid of Great Britain Limited, Gosport, Hampshire, United Kingdom | Zoton |
Dated this 30th day of May 1996.
HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1996, No 57
NZLII —
NZ Gazette 1996, No 57
β¨ LLM interpretation of page content
π₯ Corrigendum to Medicines Act 1981 Notice
π₯ Health & Social Welfare31 May 1996
Medicines Act, Corrigendum, Ganciclovir
- HUGH BABER, Assistant General Manager, Health Regulation and Protection
π₯ Provisional Consent to the Distribution of New Medicines
π₯ Health & Social Welfare30 May 1996
Medicines Act, Provisional Consent, Lamivudine, Saquinavir mesylate
- HUGH BABER, Assistant General Manager, Health Regulation and Protection
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare30 May 1996
Medicines Act, Changed Medicines, Acetylsalicylic acid, Benzoyl peroxide, Rocuronium bromide, Somatropin, Risperidone, Roxithromycin, Lansoprazole
- HUGH BABER, Assistant General Manager, Health Regulation and Protection